![Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US - Connected-vet Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US - Connected-vet](https://connected-vet.com/wp-content/uploads/2024/02/Imprimed.png)
Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US - Connected-vet
![IMPRIMED: Biotecnología aplicada a la obtención de polímeros imprimibles para aplicaciones biomédicas a partir de subproductos de origen agroalimentario de Navarra. - AIN : Asociación de la Industria Navarra IMPRIMED: Biotecnología aplicada a la obtención de polímeros imprimibles para aplicaciones biomédicas a partir de subproductos de origen agroalimentario de Navarra. - AIN : Asociación de la Industria Navarra](https://www.ain.es/site/wp-content/uploads/logo-imprimed-504x600.jpg)
IMPRIMED: Biotecnología aplicada a la obtención de polímeros imprimibles para aplicaciones biomédicas a partir de subproductos de origen agroalimentario de Navarra. - AIN : Asociación de la Industria Navarra
![ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers | PRUndergroundPRUnderground ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers | PRUndergroundPRUnderground](https://prunderground-production-public.s3.amazonaws.com/uploads/2021/01/ImpriMed-Medicine-Services-for-Canines--1024x682.jpeg)
ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers | PRUndergroundPRUnderground
![ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology | Business Wire ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology | Business Wire](https://mms.businesswire.com/media/20231219536657/en/1974123/23/ImpriMed_Logo_Small_500x500.jpg)